Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT06228352
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-09Est. Completion: 2029-06
Enrollment target: 80 participants Locations- Hôpital Necker-Enfants Malades, Paris, France
Other microbiome trials you might be interested in
Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026
Recruiting
Recurrent C. Difficile (rCDI)Ulcerative Colitis (UC)Metabolic Syndrome (MetS)
The gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficil…
Rome, ItalyEst. completion Jan 19, 2029